insights_auto
ALMKT の上昇理由: 3.74%?
さらに詳しくchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€0.094
arrow_upward
+3.74%(+0.0034) 1 日
11月9日, 17:35:12 GMT+1 · EUR
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoALMKT の上位の分析情報を生成しています...
始値
€0.09
高値
€0.09
安値
€0.09
時価総額
1719.12万
平均出来高
55.27万
取引量
26.75万
株価収益率
0.80
52 週高値
€0.23
52 週安値
€0.07
EPS
€0.12
発行済株式数
1.95億
従業員数
56
始値
€0.09
高値
€0.09
安値
€0.09
時価総額
1719.12万
平均出来高
55.27万
取引量
26.75万
株価収益率
0.80
52 週高値
€0.23
52 週安値
€0.07
EPS
€0.12
発行済株式数
1.95億
従業員数
56
ニュース記事
情報源: ウェブソース、ニュース パートナー
プロフィール
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA について